reiterateHCAfinnhub
Oppenheimer Reiterates Outperform Rating on HCA Healthcare, Inc. (HCA)
Oppenheimer analysts reiterated a Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Oppenheimer analysts reiterated a Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreTruist Securities analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreDeutsche Bank analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreBarclays analysts reiterated a Overweight rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreKeybanc analysts reiterated a Overweight rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreJefferies analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreRBC Capital analysts reiterated a Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreUBS analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreCantor Fitzgerald analysts reiterated a Overweight rating on HCA Healthcare, Inc. (NYSE:HCA) on January 28, 2026. HCA Healthcare, Inc.
Read moreNeedham analysts reiterated a Buy rating on Palo Alto Networks, Inc. (NASDAQ:PANW) on January 28, 2026. Palo Alto Networks, Inc.
Read moreB of A Securities analysts reiterated a Neutral rating on Exxon Mobil Corporation (NYSE:XOM) on January 28, 2026. Exxon Mobil Corporation operates in the Energy sector. The stock…
Read moreMorgan Stanley analysts upgraded Johnson & Johnson (NYSE:JNJ) from Equal-Weight to Overweight on January 28, 2026. Johnson & Johnson operates in the Healthcare sector. The stock…
Read morePiper Sandler analysts reiterated a Overweight rating on Bristol-Myers Squibb Company PFD CONV 2 (OTC:BMYMP) on January 28, 2026. Bristol-Myers Squibb Company PFD CONV 2 operates…
Read moreKeybanc analysts reiterated a Overweight rating on Amazon.com, Inc. (NASDAQ:AMZN) on January 28, 2026. Amazon.com, Inc.
Read moreOppenheimer analysts reiterated a Outperform rating on Amazon.com, Inc. (NASDAQ:AMZN) on January 28, 2026. Amazon.com, Inc.
Read moreODDO BHF analysts reiterated a Buy rating on Atlas Copco AB (OTC:ATLCY) on January 28, 2026. Atlas Copco AB operates in the Industrials sector. The stock currently trades at…
Read moreODDO BHF analysts reiterated a Buy rating on Atlas Copco AB (OTC:ATLKY) on January 28, 2026. Atlas Copco AB operates in the Industrials sector. The stock currently trades at…
Read moreJEFFERIES analysts reiterated a Buy rating on CSL Limited (OTC:CSLLY) on January 28, 2026. CSL Limited operates in the Healthcare sector. The stock currently trades at $62.97 with…
Read moreTD COWEN analysts reiterated a Hold rating on LVMH Moët Hennessy - Louis Vuitton, Société Européenne (OTC:LVMUY) on January 28, 2026. LVMH Moët Hennessy - Louis Vuitton, Société…
Read moreCitigroup analysts initiated coverage on National Grid plc (NYSE:NGG) with a Neutral rating on January 26, 2026. National Grid plc operates in the Utilities sector. The stock…
Read more